What You Should Know: - Seven Bridges, a bioinformatics ecosystem provider, announced it is collaborating with the University of São Paulo (USP) and Google Cloud, as well as the Associação Genomas Brasil (Brazil Genome Association), to assist the DNA do Brasil (DNABr) project in building a reference genome that represents the genetic diversity of the Brazilian population. - The joint effort will advance unbiased precision medicine for underrepresented populations in Brazil through the
Read More
Why Cancer Registries are Part of America’s Fight for Racial Equality
According to a 2019 study in the Proceedings of the National Academy of Sciences, one in 1,000 Black males can expect to die at the hands of the police. Black males were also 2.5 times more likely to die during an encounter with police than white males. For some, those figures are staggering. For many others, they are reminders of the racial disparities that have existed for far too long in this country. So, in 2020, when recent events have brought racial injustice back into the national
Read More
NIH Funds First Nationwide Rare and Atypical Diabetes Network
What You Should Know: - NIH awards funding for Rare and Atypical Diabetes
Network, or RADIANT that will seek to discover the cause of
several unusual forms of diabetes. - RADIANT plans to screen about 2,000 people with unknown
or atypical forms of diabetes that do not fit the common features of type 1 and
type 2 diabetes. The National Institute of
Health (NIH), announced this week it is funding a nationwide study with The Rare and Atypical Diabetes
Network (RADIANT) that will seek
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
AMA Grants New CPT Code for KidneyIntelX to Support Medicare & Reimbursement
The American Medical Association (AMA) has granted a CPT® Proprietary Laboratory Analyses (PLA) Code for Renayltix AI’s lead product, KidneyIntelX. The new code, 0105U, has been approved and published by the AMA CPT Editorial Panel, and is scheduled to become effective on October 1, 2019.Medicare Price for New CPT CodeA payment rate for the new code will be established for Medicare patients through the 2019 Clinical Lab Fee Schedule (CLFS) Annual Public Meeting process. Renayltix AI will shortly
Read More
HIMSS19 Day 2 Announcements & Summary
Accenture: Millenials & Gen Z Are Shifting to Virtual, Retail, Clinic, Digital CareMillennial and Gen Z consumers in the U.S. are rapidly adopting non-traditional care models, such as retail clinics, virtual and digital services, according to results of an Accenture survey of 2,000 consumers.Key findings of the survey study include:- When considering traditional in-person care, millennials (ages 22 to 38 in 2019) were two to three times more likely than baby boomers (ages 55 to 73) to be
Read More
Genoox Raises $6M to Bring Clinical Genomics to U.S. Medical Centers
Genoox, a genomic analysis startup making it easier for doctors, clinicians and researchers to analyze and act on genetic sequencing results by applying various clinical applications has announced a $6 million investment today, led by Triventures and joined by Inimiti Capital Partners and Glilot Capital Partners. Genetic analysis takes other systems hours, but takes Genoox minutes, enabling clinical genomics to become available to millions who don’t have access to top 10 academic centers.Founded
Read More
Genoox & Bionano Partner to Detect Disease-Causing Structural Variants
Genoox, a genetic data analysis company, recently partnered with Bionano Genomics to better identify the nearly 20k potentially disease-causing SVs in the human genome. By combining Genoox technology and Bionano mapping data, the new Genoox integrated platform will offer clinicians a single platform for accurate detection of genetic mutations for rare disease. Genoox and Bionano intend to co-sell and co-market the integrated platform for research and future clinical applications.Children’s
Read More
Genomic Analysis Startup Genoox Raises $6M to Expand in the US Market
Genoox, the genomic analysis company making it easier for doctors, clinicians, and researchers to analyze and act on genetic sequencing data has raised $6 million in funding led by Inimiti Capital Partners and Glilot Capital Partners. With this investment, Genoox will also be expanding their genomic services into the U.S. healthcare market, providing medical facilities with innovative solutions to help solve real and pressing healthcare problems. Genoox has an international footprint, with a
Read More
Penn Medicine’s Abramson Cancer Center Launches Initiative to Improve & Personalize BRCA Mutations
Cancer experts at the Basser Center for BRCA in the Abramson Cancer Center of the University of Pennsylvania have announced a new collaboration with Tempus to improve and personalize treatment for patients with heritable BRCA mutations. Tempus, a technology company focused on helping doctors personalize cancer treatment will analyze the molecular and clinical data of patients who were treated at the Basser Center and harbor a BRCA mutation using machine learning and advanced
Read More